Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
UBC provides a consultative approach to building protocol-specific, virtual evidence generation strategies through comprehensive decentralized solutions.
Explore NexusPartnering with the biopharmaceutical industry to provide leading late stage and patient support services focused on patient safety, access, and value.
Real Data
Real People
Real Outcomes
Our customizable and innovative tools enhance UBC’s Global Late Stage, Safety, and Patient Support Services focusing on patient safety, data security, efficiency, quality, and product value.
Learn More
Article | August 30, 2021
UBC was selected as the reimbursement hub to support the first approved therapy of its kind for the treatment of sickle cell disease and quickly advocated to include patient education and adherence services to the program. The results speak for themselves.
Read More
Article | August 24, 2021
Dr. Alexandra Thoenes, MD and Senior Project Safety Physician, discusses the guidelines the WHO released on AI in healthcare and how that affects using AI in pharmacovigilance.
Read More
Article | September 7, 2021
Ron Lacy VP of Global Product & Innovation at UBC, shares how healthcare virtual assistants are coming along and where the future could point towards.
Read MoreIf you are with a pharmaceutical or biotech company and seeking information on UBC services, please fill out the form below. For all other general inquires please message: contact@ubc.com
* required field
If you are with a pharmaceutical or biotech company and seeking information on UBC services, please fill out the form below.For all other general inquires please message: contact@ubc.com
* required field
